Articles with public access mandates - Cosima Locher, PhDLearn more
Not available anywhere: 3
Open-label placebo response–Does optimism matter? A secondary-analysis of a randomized controlled trial
C Locher, AF Nascimento, J Kossowsky, A Meyer, J Gaab
Journal of psychosomatic research 116, 25-30, 2019
Mandates: Swiss National Science Foundation
Nonpharmacological interventions for pediatric migraine: a network meta-analysis
H Koechlin, J Kossowsky, TL Lam, J Barthel, J Gaab, CB Berde, ...
Pediatrics 147 (4), 2021
Mandates: Swiss National Science Foundation
Exposure to parental depressive symptoms: a longitudinal analysis on the association with adolescents' depressive symptoms and adjustment problems
C Donado, Y Friedrich, J Kossowsky, C Locher, H Koechlin
Journal of Developmental & Behavioral Pediatrics 41 (7), 522-533, 2020
Mandates: Swiss National Science Foundation
Available somewhere: 42
Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and …
C Locher, H Koechlin, SR Zion, C Werner, DS Pine, I Kirsch, RC Kessler, ...
JAMA psychiatry 74 (10), 1011-1020, 2017
Mandates: Swiss National Science Foundation, US National Institutes of Health
Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia
C Locher, AF Nascimento, I Kirsch, J Kossowsky, A Meyer, J Gaab
Pain 158 (12), 2320-2328, 2017
Mandates: Swiss National Science Foundation
Efficacy, safety, and acceptability of pharmacologic treatments for pediatric migraine prophylaxis: a systematic review and network meta-analysis
C Locher, J Kossowsky, H Koechlin, TL Lam, J Barthel, CB Berde, J Gaab, ...
JAMA pediatrics 174 (4), 341-349, 2020
Mandates: Swiss National Science Foundation
Artificial intelligence and the future of psychiatry: qualitative findings from a global physician survey
C Blease, C Locher, M Leon-Carlyle, M Doraiswamy
Digital health 6, 2055207620968355, 2020
Mandates: Swiss National Science Foundation, Irish Research Council
Open-label placebo clinical trials: is it the rationale, the interaction or the pill?
CR Blease, MH Bernstein, C Locher
BMJ evidence-based medicine 25 (5), 159-165, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health, Irish …
Psychotherapy: a world of meanings
C Locher, S Meier, J Gaab
Frontiers in psychology 10, 460, 2019
Mandates: Swiss National Science Foundation
Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial
AF Nascimento, J Gaab, I Kirsch, J Kossowsky, A Meyer, C Locher
BMJ open 10 (2), e032868, 2020
Mandates: Swiss National Science Foundation
Talking to children and families about chronic pain: The importance of pain education—An introduction for pediatricians and other health care providers
H Koechlin, C Locher, A Prchal
Children 7 (10), 179, 2020
Mandates: Swiss National Science Foundation
The other side of the coin: nocebo effects and psychotherapy
C Locher, H Koechlin, J Gaab, H Gerger
Frontiers in psychiatry 10, 555, 2019
Mandates: Swiss National Science Foundation
Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis
C Locher, J Kossowsky, J Gaab, I Kirsch, P Bain, P Krummenacher
Journal of affective disorders 181, 50-60, 2015
Mandates: Swiss National Science Foundation, US National Institutes of Health
Putting the ‘art’into the ‘art of medicine’: The under-explored role of artifacts in placebo studies
MH Bernstein, C Locher, T Kube, S Buergler, S Stewart-Ferrer, C Blease
Frontiers in psychology 11, 1354, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health, Irish …
The best treatment option (s) for adult and elderly patients with chronic primary musculoskeletal pain: a protocol for a systematic review and network meta-analysis
H Koechlin, B Whalley, NJ Welton, C Locher
Systematic reviews 8, 1-10, 2019
Mandates: Swiss National Science Foundation, UK Medical Research Council
Primary care providers' use of and attitudes towards placebos: an exploratory focus group study with us physicians
MH Bernstein, C Locher, S Stewart‐Ferrer, S Buergler, CM DesRoches, ...
British journal of health psychology 25 (3), 596-614, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health, Irish …
What are the key characteristics of a ‘good’psychotherapy? Calling for ethical patient involvement
H Gerger, AF Nascimento, C Locher, J Gaab, M Trachsel
Frontiers in psychiatry 11, 406, 2020
Mandates: Swiss National Science Foundation
Attitudes about informed consent: An exploratory qualitative analysis of UK psychotherapy trainees
CR Blease, T Arnott, JM Kelley, G Proctor, T Kube, J Gaab, C Locher
Frontiers in Psychiatry 11, 183, 2020
Mandates: Swiss National Science Foundation, Irish Research Council
US primary care in 2029: A Delphi survey on the impact of machine learning
C Blease, A Kharko, C Locher, CM DesRoches, KD Mandl
PLoS One 15 (10), e0239947, 2020
Mandates: Swiss National Science Foundation, Irish Research Council
Efficacy and safety of SSRIs, SNRIs, and placebo in common psychiatric disorders: a comprehensive meta-analysis in children and adolescents
MC Locher, MH Koechlin, MSR Zion, MC Werner, DS Pine, I Kirsch, ...
JAMA psychiatry 74 (10), 1011, 2017
Mandates: Swiss National Science Foundation, US National Institutes of Health
Publication and funding information is determined automatically by a computer program